- Exchange: JASDAQ
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Services
- Sub-Industry: Medical Labs&Testing Srv
tella Inc+ Add to Watchlist
2191:JP3,200 JPY 320 11.11%
As of 02:10:05 ET on 05/24/2013.
Company Profile for tella Inc (2191)
tella, Inc. provides cancer treatment and know-hows to contracted medical institutions. The company supports these medical institutions by offering dendritic cell vaccine treatment and other technology that chemical therapy and actinotherapy combined.
Key Executives for tella Inc (2191)
|Yuichiro YazakiPresident/Founder||Naoko IinoDirector|
|Ryohei YamamotoDirector||Hideki MatsubaraDirector|